Authors:
Friedhoff, LT
Cullen, EI
Geoghagen, NSM
Buxbaum, JD
Citation: Lt. Friedhoff et al., Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide, IN J NEUROP, 4(2), 2001, pp. 127-130
Authors:
Vattemi, G
Engel, WK
McFerrin, J
Buxbaum, JD
Pastorino, L
Askanas, V
Citation: G. Vattemi et al., Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis, LANCET, 358(9297), 2001, pp. 1962-1964
Authors:
Hakak, Y
Walker, JR
Li, C
Wong, WH
Davis, KL
Buxbaum, JD
Haroutunian, V
Fienberg, AA
Citation: Y. Hakak et al., Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia, P NAS US, 98(8), 2001, pp. 4746-4751
Authors:
Sabo, SL
Ikin, AF
Buxbaum, JD
Greengard, P
Citation: Sl. Sabo et al., The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement, J CELL BIOL, 153(7), 2001, pp. 1403-1414
Authors:
Osawa, M
Tong, KI
Lilliehook, C
Wasco, W
Buxbaum, JD
Cheng, HYM
Penninger, JM
Ikura, M
Ames, JB
Citation: M. Osawa et al., Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3, J BIOL CHEM, 276(44), 2001, pp. 41005-41013
Authors:
Choi, EK
Zaidi, NF
Miller, JS
Crowley, AC
Merriam, DE
Lilliehook, C
Buxbaum, JD
Wasco, W
Citation: Ek. Choi et al., Calsenilin is a substrate for caspase-3 that preferentially interacts withthe familial Alzheimer's disease-associated C-terminal fragment of presenilin 2, J BIOL CHEM, 276(22), 2001, pp. 19197-19204
Authors:
Ho, L
Purohit, D
Haroutunian, V
Luterman, JD
Willis, F
Naslund, J
Buxbaum, JD
Mohs, RC
Aisen, PS
Pasinetti, GM
Citation: L. Ho et al., Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease, ARCH NEUROL, 58(3), 2001, pp. 487-492
Authors:
Buxbaum, JD
Silverman, JM
Smith, CJ
Kilifarski, M
Reichert, J
Hollander, E
Lawlor, BA
Fitzgerald, M
Greenberg, DA
Davis, KL
Citation: Jd. Buxbaum et al., Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity, AM J HU GEN, 68(6), 2001, pp. 1514-1520
Authors:
Buxbaum, JD
Lilliehook, C
Chan, JY
Go, RCP
Bassett, SS
Tanzi, RE
Wasco, W
Blacker, D
Citation: Jd. Buxbaum et al., Genomic structure, expression pattern, and chromosomal localization of thehuman calsenilin gene: no association between an exonic polymorphism and Alzheimer's disease, NEUROSCI L, 294(3), 2000, pp. 135-138
Authors:
Harroch, S
Palmeri, M
Rosenbluth, J
Custer, A
Okigaki, M
Shrager, P
Blum, M
Buxbaum, JD
Schlessinger, J
Citation: S. Harroch et al., No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta, MOL CELL B, 20(20), 2000, pp. 7706-7715
Authors:
Naslund, J
Haroutunian, V
Mohs, R
Davis, KL
Davies, P
Greengard, P
Buxbaum, JD
Citation: J. Naslund et al., Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline, J AM MED A, 283(12), 2000, pp. 1571-1577
Citation: C. Rio et al., Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4, J BIOL CHEM, 275(14), 2000, pp. 10379-10387
Authors:
Perry, E
Martin-Ruiz, C
Lee, M
Griffiths, M
Johnson, M
Piggott, M
Haroutunian, V
Buxbaum, JD
Nasland, J
Davis, K
Gotti, C
Clementi, F
Tzartos, S
Cohen, O
Soreq, H
Jaros, E
Perry, R
Ballard, C
McKeith, I
Court, J
Citation: E. Perry et al., Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy bodydiseases, EUR J PHARM, 393(1-3), 2000, pp. 215-222
Authors:
Sabo, SL
Lanier, LM
Ikin, AF
Khorkova, O
Sahasrabudhe, S
Greengard, P
Buxbaum, JD
Citation: Sl. Sabo et al., Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein, J BIOL CHEM, 274(12), 1999, pp. 7952-7957